Functional outcomes, reducing treatment waits are key metrics
In an attempt to address escalating costs and inconsistent quality, healthcare systems are shifting from traditional fee-for-service, volume-based reimbursement to patient-focused, value-based approaches.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Value-based models emphasize effective, appropriate care and reward providers who achieve the best treatment outcomes at the lowest cost.
Cleveland Clinic Cancer Center has embraced the value-based care approach and is scrutinizing all aspects of how cancer patients’ treatment is managed, to improve outcomes and maximize efficiency.
In this video, Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, discusses how to define and measure value in cancer care.
Photo Credit ©Russell Lee
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust